Stock CYCC CYCLACEL PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cyclacel Pharmaceuticals, Inc.

Equities

CYCC

US23254L8019

Market Closed - Nasdaq
Other stock markets
 21:30:00 22/05/2024 BST 		5-day change 1st Jan Change
2.122 USD -5.69% Intraday chart for Cyclacel Pharmaceuticals, Inc. -13.03% -20.52%
05-14 Cyclacel Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Transcript : Cyclacel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYCLACEL PHARMACEUTICALS, INC. Stock Cyclacel Pharmaceuticals, Inc.
 3.11M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. CYCC Stock
  4. Charts Cyclacel Pharmaceuticals, Inc.
  5. Sector Chart